Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
Allopregnanolone: State of the art.
Applications of optical coherence tomography in pediatric clinical neuroscience.
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
Reversed takotsubo cardiomyopathy in a patient with new-onset multiple sclerosis: Cause, link, or just coincidence?
Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.
Development of the Oxford Participation and Activities Questionnaire: constructing an item pool.
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Ten Years of Proteomics in Multiple Sclerosis.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Management of neurogenic bladder in patients with multiple sclerosis.
Functional Assessment of Multiple Sclerosis.
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.

Pages